Intensity Therapeutics, Inc. (INTS) PT Lowered to $1.50 at Benchmark
Tweet Send to a Friend
(Updated - August 20, 2025 7:37 AM EDT)
Benchmark analyst Robert Wasserman lowered the price target on Intensity Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Benchmark analyst Robert Wasserman lowered the price target on Intensity Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
